Correct Mobilization Time After Implantation of an Intracardiac Electronic Device Implantation

NCT ID: NCT06330675

Last Updated: 2025-08-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

558 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-01

Study Completion Date

2027-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Bedrest is usually prescribed for patients management after cardiac electronic device implantation (CIED) in order to prevent complication. Due to the lack of guidelines available on the timing of postoperative mobilization management, the aim of the study is to evaluate the safety of early mobilization, comparing mobilization at 4-h against day-after procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pacemaker Defibrillators, Implantable

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mobilization 4-h after procedure

Short-term bed-rest (4-h) after CIED implantation

Group Type EXPERIMENTAL

Early mobilization

Intervention Type OTHER

Short-term bed-rest and immobilization

Mobilization day-after procedure

Standard of care with prolungate bed-rest after CIED implantation

Group Type ACTIVE_COMPARATOR

Standard of care

Intervention Type OTHER

Bed-rest and immobility until the day-after procedure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early mobilization

Short-term bed-rest and immobilization

Intervention Type OTHER

Standard of care

Bed-rest and immobility until the day-after procedure

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 18 years old
* Signed informed consent form
* New permanent pacemaker implantation (PM) or implantable cardioverter-defibrillator (ICD)

Exclusion Criteria

* CIED implants after recent cardiac surgery
* Upgrade or revision of implanted device
* CRT implantation
* Intraoperative complications
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cardiocentro Ticino

OTHER

Sponsor Role collaborator

Caporali Elena

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Caporali Elena

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elena Caporali, MD

Role: PRINCIPAL_INVESTIGATOR

Cardiocentro Ticino Institute - EOC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cardiocentro Ticino Institute - EOC

Lugano, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Elena Caporali, MD

Role: CONTACT

+41 (0)91 811 53 24

Michele Villa, RN

Role: CONTACT

+41 (0)91 811 50 59

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Elena Caporali, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-01820

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CRT-P or CRT-D in Dilated Cardiomyopathy
NCT04139460 NOT_YET_RECRUITING NA